REVVITY, INC Increase (Decrease) in Unbilled Receivables
REVVITY, INC (RVTY) reported Increase (Decrease) in Unbilled Receivables of $22.40 million for the 12-month period ending 2019-12-29, per its 10-K filed 2020-02-25.
Discontinued › Notes
us-gaap:IncreaseDecreaseInUnbilledReceivables · last filed 2020-02-25
- REVVITY, INC increase (decrease) in unbilled receivables for the quarter ending 2019-12-29 was -$4.10M, a 356.25% decline year-over-year.
- REVVITY, INC increase (decrease) in unbilled receivables for the quarter ending 2019-09-29 was $1.20M.
- REVVITY, INC increase (decrease) in unbilled receivables for the quarter ending 2019-06-30 was $2.80M, a 77.95% decline year-over-year.
- REVVITY, INC increase (decrease) in unbilled receivables for the quarter ending 2019-03-31 was $22.50M, a 6.25% decline year-over-year.
- REVVITY, INC increase (decrease) in unbilled receivables for fiscal 2019 was $22.40M, a 27.97% decline from fiscal 2018.
- REVVITY, INC increase (decrease) in unbilled receivables for fiscal 2018 was $31.10M.
| Period end | Increase (Decrease) in Unbilled Receivables 3 month | Increase (Decrease) in Unbilled Receivables 6 month | Increase (Decrease) in Unbilled Receivables 9 month | Increase (Decrease) in Unbilled Receivables 12 month |
|---|---|---|---|---|
| 2019-12-29 | -$4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$2.90M derived: sum of 2 quarters · filed 2020-02-25 | -$100.00K derived: sum of 3 quarters · filed 2020-02-25 | $22.40M 10-K · filed 2020-02-25 |
| 2019-09-29 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $4.00M derived: sum of 2 quarters · filed 2019-11-05 | $26.50M 10-Q · filed 2019-11-05 | $28.10M derived: sum of 4 quarters · filed 2020-02-25 |
| 2019-06-30 | $2.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $25.30M 10-Q · filed 2019-08-06 | $26.90M derived: sum of 3 quarters · filed 2020-02-25 | $19.70M derived: sum of 4 quarters · filed 2020-02-25 |
| 2019-03-31 | $22.50M 10-Q · filed 2019-05-07 | $24.10M derived: sum of 2 quarters · filed 2020-02-25 | $16.90M derived: sum of 3 quarters · filed 2020-02-25 | $29.60M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-12-30 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$5.60M derived: sum of 2 quarters · filed 2020-02-25 | $7.10M derived: sum of 3 quarters · filed 2020-02-25 | $31.10M 10-K · filed 2020-02-25 |
| 2018-09-30 | -$7.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $5.50M derived: sum of 2 quarters · filed 2018-11-06 | $29.50M 10-Q · filed 2018-11-06 | |
| 2018-07-01 | $12.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $36.70M 10-Q · filed 2018-08-07 | ||
| 2018-04-01 | $24.00M 10-Q · filed 2018-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |